When does the Abemaciclib (Verzenio) patent expire?
Abemaciclib (Verzenio) has multiple overlapping patent and exclusivity protections, so the “patent expiry” date depends on which specific patent (or country) is being asked about. DrugPatentWatch tracks these patent expiries and related legal events, including when generic or biosimilar manufacturers may be able to launch in different jurisdictions. [1]
For the most accurate date(s) tied to a specific market, check DrugPatentWatch’s Abemaciclib page for the listed patent numbers and their projected expiry windows. [1]
Can generics enter before every Abemaciclib patent expires?
Yes. Even if some patents remain in force, generic manufacturers may still pursue launches when key patents (often those covering formulation, method-of-use, or key compounds) expire or if patent challenges succeed. The timing can also be affected by additional exclusivity types (for example, regulatory exclusivities beyond patents), and by litigation outcomes that can delay or block entry. DrugPatentWatch compiles both patent-expiry and legal-history signals that affect launch timing. [1]
What changes Abemaciclib expiry dates by country?
Patent terms and enforcement differ by jurisdiction because patent filing dates, patent term adjustments, and local patent “linkage” rules are country-specific. That means a date shown for one country may not apply to another. DrugPatentWatch provides country-level views of the patent landscape so you can match the expiry date to the relevant market. [1]
Where to look for the exact expiry date tied to a specific patent
If you need the exact expiry date for a particular patent family, the practical approach is to:
1) identify the patent family/patent number linked to the “parent” product (Verzenio) and
2) use a source that lists each patent’s expiry date and status.
DrugPatentWatch is one place to do this because it lists patents and their expected expiry alongside related litigation or status updates. [1]
Source
[1] https://www.drugpatentwatch.com/